| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to pharmaceutical industry. An aqueous solution of a medical composition containing 20(R)-ginsenoside Rg3, with the certain ginsenoside Rg3 content in the solution (versions). A method of preparing the aqueous solution of the medical composition containing 20(R)-ginsenoside Rg3 (versions). A method of preparing a lyophilised powder for injection of the medical composition containing 20(R)-ginsenoside Rg3 (versions). The aqueous solution stated above contains total dissolved 20(R)-ginsenoside Rg3 and exhibits higher bioavailability. The solution and based compositions can be used for preparing an injection solution for oral administration and external application. n EFFECT: medical composition containing 20(R)-ginsenoside Rg3 is applicable for preparing the drug for anticancer, potentiating and toxicity-attenuating effects of the combined chemotherapy or radiation therapy for intensifying human immune functions, human memory improvement, stability to fatigue and reduced swelling, pain management and wound healing effects. n 7 cl, 11 dwg, 20 tbl, 50 ex |